David N. Korones

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

S. Andrew, Rohinton S. Tarapore, Matthew D. Hall et al. · Journal of Neuro-Oncology · 2019 · 187 citations

Neuro-oncology, Tumor Biology, Medicine +8

Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a

Carl W. White, Stephen J. Wolf, David N. Korones et al. · The Journal of Pediatrics · 1991 · 173 citations

Thrombosis, Pediatric Hematology, Hematology +5

Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma

Rajiv Mangla, Doerthe Ziegelitz, Michael T. Milano et al. · Radiology · 2010 · 172 citations

Neuro-oncology, Radiation-temozolomide Therapy, Oncology +10

Patterns and Timing of Recurrence After Temozolomide-Based Chemoradiation for Glioblastoma

Michael T. Milano, Paul Okunieff, Rosemary S. Donatello et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 159 citations

Neuro-oncology, Temozolomide-based Chemoradiation, Radiation Therapy +10

Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study

Michael T. Milano, Mahlon D. Johnson, Joohee Sul et al. · Journal of Neuro-Oncology · 2009 · 146 citations

Neuro-oncology, Spinal Cord Injury, Spinal Disorder +10